Nurse Practitioner, Adult Health · Brentwood, NY
NPI
1588017164
Since 2016
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
55 2nd Ave Unit 2
Brentwood, NY, 11717
Phone (631) 983-3237
Groups this clinician bills Medicare through
Medicare paid, 2023
$3,237
112 services
Medicare patients, 2023
22
Average age 73
Drug cost, 2024
$904K
6,709 prescriptions
Company payments, 2025
$454
From 12 companies
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-23.
| Medicare paid |
|---|
| 80305 Drug Tests | 29 | 22 | $12.54 | $364 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 29 | 22 | $245.81 | $7,129 |
Medicare prescription drug claims, 2024
In 2024, the drug Mubushar I Raza prescribed most often to Medicare patients was Oxycodone Hcl, with 1,030 prescriptions and refills. In total Mubushar I Raza wrote 6,709 Medicare prescriptions that cost $904K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 1,030 | 1,030 | 184 | $27K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 709 | 709 | 140 | $40K |
| Lidocaine Generic | 466 | 470 | 82 | $50K |
| Gabapentin Generic | 461 | 510 | 109 | $3,942 |
| Diclofenac Sodium Generic | 306 | 315 | 59 | $89K |
| Tizanidine Hcl Generic | 285 | 301 | 61 | $4,108 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 257 | 257 | 60 | $6,939 |
| Tramadol Hcl Generic | 186 | 186 | 41 | $6,402 |
| Morphine Sulfate Er Morphine Sulfate | 185 | 185 | 30 | $6,450 |
| Oxycontin Oxycodone Hcl | 162 | 162 | 23 | $128K |
| Cyclobenzaprine Hcl Generic | 152 | 155 | 47 | $2,244 |
| Methadone Hcl Generic | 131 | 131 | 23 | $3,232 |
| Pregabalin Generic | 129 | 129 | 30 | $5,300 |
| Mounjaro Tirzepatide | 118 | 122 | 29 | $125K |
| Carisoprodol Generic | 115 | 115 | 20 | $1,123 |
Brand drugs: - claims; generic drugs: 5,678 claims; opioid claims: 2,905.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mubushar I Raza $454 ($454 in general payments such as food, travel and fees) from 12 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $91.96.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $91.96 |
| TerSera Therapeutics LLC | 3 | $78.96 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $57.18 |
| Abbvie Inc. ABBV | 3 | $46.3 |
| Scilex Pharmaceuticals Inc. | 2 | $42.9 |
| Novo Nordisk Inc NVO | 1 | $23.07 |
| Orexo US, Inc. | 1 | $22.93 |
| Pfizer Inc. PFE | 1 | $20.71 |
| Collegium Pharmaceutical, Inc. COLL | 1 | $18.63 |
| Intra-Sana Laboratories | 1 | $18.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.